Anixa Biosciences, Inc. (ANIX)
3.13
+0.02
(+0.64%)
USD |
NASDAQ |
Jan 21, 15:48
Anixa Biosciences Shareholders Equity (Quarterly): 15.16M for Oct. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Merck & Co., Inc. | 51.85B |
| Boston Scientific Corp. | 23.39B |
| Puma Biotechnology, Inc. | 115.27M |
| CEL-SCI Corp. | 15.96M |
| AIM ImmunoTech, Inc. | -6.077M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.08M |
| Total Liabilities (Quarterly) | 2.13M |
| Debt to Equity Ratio | 0.0135 |
| Current Ratio | 8.077 |
| Net Debt Paydown Yield | 0.00% |